Qiagen (QGEN) Financials: Revenue & Earnings
QGEN$50.38+0.04 +0.09%
$10.38B
Market Cap
25.83
P/E
20.66
Forward P/E
50
Score
Qiagen (QGEN) Financials: Revenue & Earnings
QGEN price $50.38 +0.04 +0.09%
- Ticker
- QGEN
- Price
- $50.38
- Change
- +0.04 +0.09%
- Market cap ?
- $10.38B
- P/E ?
- 25.83
- Forward P/E ?
- 20.66
- Dividend yield ?
- 5.24%
- Beta ?
- 0.61
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Stocklytics score
- 50
- Value
- 34
- Quality
- 77
- Growth
- 40
Stocklytics score rationale: value 34, quality 77, growth 40.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 1337991000 | 1417536000 | 1501848000 | 1526424000 | 1870346000 | 2251657000 | 2141518000 | 1965311000 | 1978214000 | 2089998999 |
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary…
Earnings and financials
Qiagen N.V. (QGEN) trades at $50.38, with a market cap of $10.38B and a trailing P/E of 25.83. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 1337991000 | 1417536000 | 1501848000 | 1526424000 | 1870346000 | 2251657000 | 2141518000 | 1965311000 | 1978214000 | 2089998999 |
Insights · Dividends · Forecast · Financials · Learn